HIKMA PHARMACEUTICALS
- Country
- 🇮🇳India
- Ownership
- Subsidiary
- Established
- 1978-01-01
- Employees
- -
- Market Cap
- $5.8B
- Website
- http://www.hikma.com
Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 20
- Registration Number
- NCT06572982
Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 32
- Registration Number
- NCT06326697
- Locations
- 🇸🇦
King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 57
- Registration Number
- NCT05563818
- Locations
- 🇸🇦
Jeddah Psychiatry Hospital, Jeddah, Saudi Arabia
🇩🇿Mustapha University Hospital, Algiers, Algeria
🇯🇴Mental Health Hub, Amman, Jordan
Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
- Conditions
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 30
- Registration Number
- NCT05423769
- Locations
- 🇪🇬
Neuropsychiatry department, Faculty of Medicine, Alexandria University Hospitals, Hadra University Hospital, Alexandria, Egypt
🇪🇬Faculty of medicine Ain shams Research Institute-Clinical Research Center (MASRI-CRC), Cairo, Egypt
Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 240
- Registration Number
- NCT05282108
- Locations
- 🇪🇬
National Cancer Institute (NCI), Cairo, Egypt
🇪🇬Nasser Institute, Cairo, Egypt
Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region
- Conditions
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 160
- Registration Number
- NCT04468165
- Locations
- 🇪🇬
New University Hospital, Alexandria, Egypt
🇯🇴King Abdullah University Hospital (KAUH), Ar Ramtha, Jordan
🇪🇬Demerdash hospital (Ain Shams University), Cairo, Egypt
Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 56
- Registration Number
- NCT03625388
- Locations
- 🇯🇴
King Hussein Cancer Center (KHCC), Amman, Jordan
🇯🇴Jordan University Hospital (JUH), Amman, Jordan
🇹🇳Aziza Othmana Hospital, Tunis, Tunisia
Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan
- Conditions
- First Posted Date
- 2018-05-08
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 12
- Registration Number
- NCT03517982
- Locations
- 🇯🇴
Prince Hamza Hospital, Amman, Jordan
Efficacy and Safety of a Generic Rosuvastatin in a Real-world Setting
- Conditions
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2018-05-07
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 317
- Registration Number
- NCT03516955
Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.
- Conditions
- Interventions
- First Posted Date
- 2018-03-09
- Last Posted Date
- 2020-03-05
- Lead Sponsor
- Hikma Pharmaceuticals LLC
- Target Recruit Count
- 9
- Registration Number
- NCT03460678
- Locations
- 🇯🇴
King Hussein Cancer Center (KHCC), Amman, Jordan
🇱🇧American University of Beirut Medical Center, Beirut, Lebanon